Evidence map›Paper›PMID 30564117›Full record

ArticleFrontiers in pharmacology2018

Cost-Utility Analysis of Venous Thromboembolism Prophylaxis Strategies for People Undergoing Elective Total Hip and Total Knee Replacement Surgeries in the English National Health Service.

Dalia M Dawoud, David Wonderling, Jessica Glen, Sedina Lewis, Xavier L Griffin, Beverley J Hunt, Gerard Stansby, Michael Reed, Nigel Rossiter, Jagjot Kaur Chahal and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Observational
  9. Is there a role for low-dose DOACs as prophylaxis?Hematology. American Society of Hematology. Education Program · 2019
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 2 countries.

Dalia M DawoudClinical Pharmacy Department, Faculty of Pharmacy, Cairo University, Giza, Egypt.
David WonderlingNational Guideline Centre, Royal College of Physicians-London, London, United Kingdom.
Jessica GlenNational Guideline Centre, Royal College of Physicians-London, London, United Kingdom.
Sedina LewisNational Guideline Centre, Royal College of Physicians-London, London, United Kingdom.
Xavier L GriffinNuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.
Beverley J HuntGuy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
Gerard StansbyNorthern Vascular Unit, Freeman Hospital, Newcastle University and Newcastle Hospitals, Newcastle upon Tyne, United Kingdom.
Michael ReedNorthumbria Healthcare NHS Foundation Trust, North Shields, United Kingdom.
Nigel RossiterDepartment of Trauma & Orthopaedic Surgery, Basingstoke & North Hampshire Hospital, Basingstoke, United Kingdom.
Jagjot Kaur ChahalBarts Health NHS Trust, London, United Kingdom.
Carlos SharpinNational Guideline Centre, Royal College of Physicians-London, London, United Kingdom.
Peter BarryUniversity Hospitals of Leicester NHS Trust, Leicester, United Kingdom.
Royal College of Physicians · GBBarts Health NHS Trust · GBBasingstoke and North Hampshire Hospital · GBFreeman Hospital · GBGuy's and St Thomas' NHS Foundation Trust · GBNorthumbria Healthcare NHS Foundation Trust · GBNuffield Orthopaedic Centre · GBUniversity Hospitals of Leicester NHS Trust · GBUniversity of Hertfordshire · GB

Funding

Department of Health 16/114/15
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cost utility analysis (CUA)direct-acting oral anticoagulantsNICE guidelinepharmacoeconomicstotal hip replacement (THR)total knee replacement (TKR)venous thromboembolism (VTE) prophylaxis

Identifiers

PMID30564117
PMCPMC6289021
OpenAlexW2903113101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.